Blue lines on black background represents our team’s integrated approach to providing the future of medical imaging.

Our Team

WE BELIEVE the future of image analysis is dependent on products that deliver new information that seamlessly integrates into existing protocols without changing patterns of operational norms. We are leading this belief through product innovation, pioneering talent, and a commitment to simplicity of use.

Management Team

Stuart Kozlick

Chief Executive Officer
Imago Systems, Inc.

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Chief Medical Officer
Interventional Cardiology

John Léger

Chief Operating Officer
Imago Systems, Inc.

Karen Morgan, Ph.D.

VP Product Development and Engineering
Imago Systems, Inc.

Scott Hallihan

Director of Program Management
Imago Systems, Inc.

John Boney

VP, Investor Relations
Imago Systems, Inc.

Members of the Board

Thomas E. (“Tom”) Ramsay - Founder, Chairman and CEO, Imago Systems, Inc.

Thomas E. (“Tom”) Ramsay

Director/Founder

Susan Alpert, M.D., PH.D. - Member of the Board of Directors

Susan Alpert, M.D., Ph.D.

Director

Mark Libratore - Member of the Board of Directors

Mark Libratore

Director

Jeannette McGill Corbett - Member of the Board of Directors

Jeannette McGill Corbett

Director

James J. ("Jim") Hallihan

Director

Eric A. Bennett

Chairman, Director

Clayton Taylor

Director

Ghassan Kassab

Director

Jim Rapp

Director

Clinical Advisory Board

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Chief Medical Officer
Interventional Cardiology

Tom Martyak, M.D.

Medical Advisory Board
Cardiovascular Medicine

Patricia Cole - Headshot

Patricia Cole, M.D., Ph.D.

Medical Advisory Board
Radiology - Cardiology - Oncology

Fethi Benraouane, M.D.

Clinical Advisory Board
Cardiologist at Houston Methodist

Dr. Richard Schatz

Clinical Advisory Board and Consultant
Cardiologist/Scientist

Dr. Richard L. Ellis, MD

Radiology

Dr. Christian Khoury, MD

Internal Medicine

Stuart Kozlick

Chief Executive Officer
Imago Systems, Inc.

As a visionary and customer-focused leader, Stuart Kozlick, P.Eng., M.A.Sc., boasts over 20 years as a distinguished MedTech Executive within the Montréal and Québec ecosystem. Specializing in medical device and technology development, innovation, clinical research, and commercialization, Stuart is recognized for his strategic leadership in seamlessly integrating and developing complex medical device systems within clinical environments. His expertise extends to early-stage ventures, where he excels in market analysis, needs assessment, and the definition of product and business models, showcasing a passion for driving innovative solutions. Throughout his career, Stuart has been at the forefront of leading and launching impactful research, product development, and clinical engineering programs. His commitment remains unwaveringly focused on the ever-growing medical ecosystem, where he dedicates himself to accelerating the adoption and accessibility of disruptive medical technology, ultimately aiming to enhance the lives of patients globally. Stuart’s collaborative efforts extend across industry developers, innovators, government bodies, healthcare institutions, and academic and research institutions, making him a pivotal figure in driving progress within the MedTech landscape. Stuart’s multifaceted role as a strategic leader, entrepreneur, and collaborator underscores his dedication to shaping the future of MedTech, positioning him as a key influencer in advancing healthcare innovation within the vibrant Montréal and Québec ecosystems.

In 2019, Stuart made history as Montreal’s first Medtech Fractional Executive and Executive-In-Residence, marking a turning point in the intersection of law and medical technology through a ground-breaking partnership with Fasken law firm. Stuart’s unwavering passion and ambition played a pivotal role in fostering the growth of successful Startups, positioning Montreal as a hub for Medtech innovation. Under his guidance, Startups thrived, navigating regulations and technological advancements with finesse. Beyond traditional roles, Stuart became a force for collaboration, facilitating dynamic exchanges through workshops and events that attracted innovators and investors. Thanks to Stuart’s efforts, the Montreal Medtech scene has seen unprecedented growth, establishing itself as a global frontrunner.

In the last five years, Stuart reshaped the consulting landscape, introducing a pioneering model for strategic guidance through fractional executive arrangements. Recognizing industry needs, Stuart founded Kozlick Medical, a firm specializing in the intersection of executive leadership and consultancy. Thriving on a dynamic approach, Kozlick Medical has partnered with diverse organizations, offering strategic insights in the fast-paced Medtech world. As the founder, Stuart contributed to the success stories of various medical businesses, emphasizing the value of fractional executive models in catalyzing growth and navigating healthcare intricacies. This journey, both rewarding and reinforcing, underscores my dedication to innovative paradigms for lasting positive impact.

Amidst the dynamic executive consultancy landscape, Kozlick Medical stands as a beacon of innovation. Over five years, Kozlick Medical has woven a narrative of success through continuous evolution, surpassing conventional consulting by offering a proactive and responsive approach. Kozlick Medical’s success is rooted in client-centric solutions, recognizing each organization’s unique challenges. As a result, our consulting strategies are meticulously tailored for sustainable growth. Looking forward, Kozlick Medical aspires to perpetual innovation, redefining executive consultancy boundaries and pushing for new avenues of growth. Its journey is a testament to the transformative power of adaptability and strategic insight, focusing on being catalysts for progress and architects of lasting success.

Stuart received a Bachelor of Engineering and a Master of Science in Engineering in Mechanical Engineering from Concordia University and a Graduate Certificate in Engineering from MIT.

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Chief Medical Officer
Interventional Cardiology

Sanjay Bhojraj, M.D., is an interventional cardiologist at Mission Heritage Medical Group in Ladera Ranch, California. He specializes in interventional cardiology and has over 19 years of experience in the field of medicine.

EXPERIENCE
Dr. Sanjay Bhojraj, M.D., is a cardiology specialist in Mission Viejo, CA. Dr. Bhojraj completed a residency at Northwestern Center Feinberg School of Medicine. He currently practices at Mission Heritage Medical Group and is affiliated with Providence Mission Hospital, Mission Viejo. Dr. Bhojraj is board certified in Interventional Cardiology.

EDUCATION

  • Henry Ford Health System, Fellowship Hospital — 2010
  • Northwestern Center Feinberg School of Medicine, Residency Hospital — 2005
  • Northwestern Center Feinberg School of Medicine, Internship Hospital — 2003
  • Indiana University / School of Medicine, Medical School — 2002

John Léger

Chief Operating Officer
Imago Systems, Inc.

John Léger’s experience spans more than 35 years spent nearly exclusively in the home healthcare medical supply and services channel, on a direct-to-consumer basis, in Michigan, Ohio, and Florida, initially working with Foster Medical and its acquired businesses. His career began at a time when caring for family members and providing post hospital healthcare at home was in its infancy. Key products offered through Foster included life supporting oxygen therapy and respiratory home care supplies, infusion therapy and nutritional support, as well as a full complement of sick room/rehabilitation equipment. In these communities John helped to develop and support the melding of the clinical home care team with lay professionals, delivering clinically excellent products and services to benefit the patient, family, third party payer, and the overall healthcare systems.

Serving Foster Medical’s Home Healthcare Division as Regional VP in early 1984, and after supporting acquisition consolidation of two regional suppliers in Michigan and Ohio, John relocated to Florida to lead a network of intake and distribution locations for statewide service, with revenue growth from $6M to over $30M in three years. As the VP-Area GM, John was responsible for all business disciplines, including Sales, Operations, Clinical, and Budget.
After 12 years with Foster Medical, John moved on to work with a Ft. Lauderdale-based Home Health Agency-DME-Infusion Pharmacy business serving SE Florida. Two years later, in 1991, John joined Mark Libratore at Liberty Medical Supply and took on overall operations management. After Boston-based PolyMedica acquired Liberty, John became Sr. VP of Operations, supporting sales growth to approximately $600M as Liberty became the nation’s largest and most recognized direct-to-consumer diabetes testing supplies company. Liberty continued to dominate that space, and PBM giant Medco acquired Liberty. Altogether, John worked 13 years with Liberty Medical.

After a brief non-compete period, John rejoined Liberty Medical founder, Mark Libratore, as SVP of Operations at Liberator Medical Supply, with product focus on urological catheters, ostomy supplies and accessories, diabetic testing supplies, and post-mastectomy appliances and garments. In addition to his SVP role, John became COO for Liberator Medical Holdings upon its public offering. CR Bard acquired Liberator Medical in 2016, and CR Bard was subsequently acquired by Becton Dickinson in 2017. John continued at an equivalent VP level with Liberator, ensuring organizational regulatory continuity and knowledge transfer until a mid-October of 2019 exit. After 13 years with Liberator Medical, John officially joined Imago in June 2020 as COO.

Karen Morgan, Ph.D.

VP Product Development and Engineering
Imago Systems, Inc.

Karen is responsible primarily for transitioning new technology applications from research into products. During her seven years with Imago, Karen’s work has focused on product and software development in the Human Imaging space, including for Breast and Cardiovascular imaging. These efforts range from product definition and testing to implementation of processes necessary for FDA guidance-compliant development practices.

Karen brings many years of experience in medical imaging device development in both small start-up environments and at multinational corporations Siemens and Analogic. Prior to joining Imago, Karen worked for more than a dozen years to bring an ultrasound imaging technology from university research to an FDA-approved medical device. As a member of that startup team, she was responsible for overseeing multiple government-funded research grants and contracts, as well as general product management. As the technology was proven, she helped develop Quality Management and Software Development Processes at the small business level and eventually merged these processes with those of the corporation that acquired the technology to bring the device to market. Following FDA approval, Karen was responsible for both the technical development and project management of new features for the product.

Karen holds a Bachelor of Science in Physics and a Ph.D. in Biomedical Engineering from the University of Virginia. The focus of her doctoral training was image and digital signal processing.

Scott Hallihan

Director of Program Management
Imago Systems, Inc.

Previously, Scott worked at IBM, starting in 1988 as a software test engineer and quickly going on to hold several leadership roles, primarily in product development, product marketing, business development, and channel partner alliances. Some notable partnership deals developed by Scott while at IBM include the first self-checkout offering in 1991, implementation and delivery of IBM’s first full-screen graphical user interface adapted to older legacy equipment, and a partnership agreement with Pandora.

Scott also led the concept and implementation of IBM’s global certification program where software business partners could self-certify their solution configurations on various IBM hardware/software platforms.

Scott’s experience in bringing a product concept from idea through implementation and delivery has been a perfect fit with Imago’s entry to the veterinary market.

Scott holds a B.S. in Computer Engineering from Clemson University and an M.B.A. from the Fuqua School of Business at Duke University. He is the author of two patents while at IBM, one of which is used today on every mobile phone’s user interface that provides visual feedback to support accurate typing on very small keys.

John Boney

VP, Investor Relations
Imago Systems, Inc.

John Boney has been an entrepreneur for nearly 40 years, building and guiding multiple businesses from ideation through successful operation to exit. He has significant experience in partnerships and networking, logistics, and business management.

After completing flight school, John started his own one-airplane flight school in Raleigh, North Carolina, which he built into one of the largest aviation training centers in the Southeast, adding a successful Fixed Base Operation (FBO) and being designated an Accident Prevention Counselor by the FAA.
John then saw the untapped potential of combining aviation with media sales in North Carolina. In return for receiving live air-based traffic reports, participating stations would provide drive-time radio spots that John’s sales team would sell regionally and nationally.

Utilizing his aviation network and his sales and management acumen, John added this innovative business in Raleigh and grew it into four other major markets within two years. John was eventually approached by a U.S. company to buy his growing traffic reporting company. Later, a Swiss Company bought the flight school, FBO, and aviation services.

Seeing the time was right for a real estate boom, John then partnered with a contractor to build, lease, and manage commercial buildings. He worked with architects and engineers in the design and execution of the construction while managing financing, permits, marketing, and tenant services.
John consistently takes the long view. He sees opportunities others haven’t yet detected and applies his extensive experience and vision to create win-win scenarios for customers, investors, and partners.

Thomas E. (“Tom”) Ramsay - Founder, Chairman and CEO, Imago Systems, Inc.

Thomas E. (“Tom”) Ramsay

Director/Founder

Tom Ramsay is an imaging expert with more than 40 years of experience, including numerous breakthroughs in the development of technologies for a wide range of applications. Tom holds 10 patents, either granted or pending, in the domains of optics, image processing, and computer-based machine learning.

Tom is a nationally recognized imaging expert, consulting on a wide range of scientific projects for U.S.-based and global companies, including Pioneer, Sony, Matsushita, NEC, Hitachi, 3M Corporation, American College of Radiology, Radiological Society of North America, American Society of Clinical Pathologists, CDC (Asia), United Nations, Lockheed, Northrop Grumman, U.S. Department of Homeland Security, and Thomson CSF (France).

Tom’s experience also includes several senior level positions, including managing projects for Sony, NEC, Hitachi, Pioneer, and others. He has invented a wide range of technologies for image processing, optical disk recording, and the radiology community, including co-invention of the first PACS (picture archiving and communications system) for breast imaging while serving as CEO of Image PSL—an innovator in image processing and medical training in partnership with the Mayo Clinic and Yale Medical School.

Tom’s background also includes several startups organized around his inventions, including the development of technologies to create a national product imaging database for Japan; photo microscopy analysis of tuberculosis in Africa; image-based gem trading in Thailand; explosive detection through analysis of X-ray images generated by portable bomb technician systems and through analysis of images generated by X-ray scanners of carry-on luggage moving through TSA airport checkpoints; fingerprint optimization analysis for the FBI; and the restoration of Thomas Edison’s movies for the Library of Congress in Washington, D.C.

In 2013, Tom was honored with an Alumnus of Notable Achievement Award from the University of Minnesota for his contributions in medicine and image processing. He also served as a member of the Emerging Technologies Advisory Group (EmTAG), a select advisory panel of the Association for Information and Image Management (AIIM).

Tom holds a Bachelor of Arts from the University of Minnesota.

Susan Alpert, M.D., PH.D. - Member of the Board of Directors

Susan Alpert, M.D., Ph.D.

Director

Susan is Principal of SFA Regulatory, LLC, a consultancy to companies placing products into the U.S. healthcare market. Prior to SFA, Susan spent 8 years at Medtronic, where she served in many roles, including Senior Vice President of Global Regulatory Affairs from November 2005 to May 2011. At Medtronic, Susan was responsible for the company’s quality, regulatory, and clinical compliance efforts, including overseeing health policy and payment.

Prior to joining Medtronic, Susan served as Vice President of Regulatory Sciences at C.R. Bard Inc. Before joining Bard, Susan served at the FDA where she held a variety of positions in the Centers dealing with drugs, devices and radiological health, and foods, including six years as the Director of the Office of Device Evaluation.

Susan has served on the board of the Food and Drug Law Institute (FDLI), was a Director of the Medical Technology Leadership Forum (MTLF), and a Director of the Women Business Leaders (WBL), and is the immediate past chair of the board of the Society for Women’s Health Research (SWHR). She is a microbiologist and pediatrician with a specialty in infectious diseases and has practical experience in laboratory research and clinical trials.

Susan holds an M.S. and Ph.D. in Biomedical Sciences (Microbiology) from New York University. She received her M.D. from the University of Miami and completed her clinical training at Montefiore Medical Center in New York and at Children’s National Medical Center in Washington, DC. She completed her undergraduate degree at Barnard College, Columbia University.

Mark Libratore - Member of the Board of Directors

Mark Libratore

Director

Mark has over 30 years of healthcare experience, and is the founder and former CEO of Liberation LLC, a Florida Corporation. He also serves as a consultant to, and investor in, several private and public companies. From 2007 to 2016, Mark founded and served as CEO and President of Liberator Medical Holdings, Inc. (LBMH, NYSE), which was acquired by C.R. Bard.

Mark founded Liberty Medical Supply Inc. in 1990 and served as its President and Chief Executive Officer. He sold the company to PolyMedica Corporation (PLMD, NYSE) in August 1996, and remained as President of Liberty Medical and Vice President of PolyMedica until February 1999.

Prior to Liberty Medical Supply, Mark founded Action Medical Supply, Inc., which was the basis for Liberator Medical Holdings. Before that, at the early stage of the rapidly growing home medical care industry, Mark started a successful home medical equipment company, Ambassador Inhalation and Respiratory Services Inc., which grew to multiple locations in Florida and was acquired by Foster Medical.

Earlier in his career, Mark worked at several Hospitals in Connecticut and Florida, including founding the Cardiopulmonary Dept. at Jupiter Hospital as its Director.

Mark has served multiple terms on the Palm Beach Board of the American Lung Association, Hospice of Martin, and various other associations. The April 1998 issue of Response Magazine voted Mark as one of the top 25 most innovative direct TV advertisers of the year, and in 2010, he was the recipient of the Florida Governor’s Business Diversification award in business expansion.

Mark is a graduate from the Hartford Hospital School of Allied Health’s Respiratory Certification Program, and has held or been responsible for licenses in clinical laboratory technology, respiratory therapy, diabetes education, pharmacy, and cardiopulmonary technology in Florida and state licenses for Home Medical Supply in 36 states.

Jeannette McGill Corbett - Member of the Board of Directors

Jeannette McGill Corbett

Director

Jeannette is a Certified Public Accountant and is currently Chair of the Finance Committee, lifetime Board Member, and President Emeritus of the Quantum Foundation, the largest health funder in Palm Beach County, Florida. Jeannette also serves on the Board of Directors of the Nicklaus Children’s Health Care Foundation. Previously, she served as CFO of the Medical Services Division and Vice President of Finance of Phymatrix Corporation (PHMX), West Palm Beach, Florida. Prior to her position at Phymatrix, Mrs. Corbett was President of McGill, Roselli, Ayala & Hoppmann, a West Palm Beach-based accounting firm. She has also served as an adjunct instructor of taxation at Palm Beach State College in Lake Worth, Florida. Mrs. Corbett has a Bachelor of Science degree in Business Administration from the University of Florida, graduating Summa Cum Laude, and a Master Degree from Palm Beach Atlantic College. Mrs. Corbett was Chairman of the Board of JFK Medical Center in Atlantis, Florida, from 1991-1994 and was Chair of the Hospital’s Finance Committee from 1989-1991.

James J. ("Jim") Hallihan

Director

Jim Hallihan brings more than 20 years of advanced technology sales and management experience, working with both manufacturers and business partners, providing him a unique understanding of the full selling cycle and how to succeed in competitive markets.

Jim offers a consultative leadership style and an exceptional track record of identifying key stakeholders and cultivating trusting, long-lasting relationships with customers. He has an effective mix of strategic development, product development management, and project leadership skills that work together to drive optimal results.

Jim is proficient in new market identification, territory development, new product introduction, and strategic business planning, having trained at some of the largest technology firms in the country. Jim’s background includes leadership positions at Symantec, Cisco, and Tandberg. During his career, he has consistently driven his teams to rank in the top percentage of sales and has achieved over 100 percent growth year after year. Jim also has extensive experience with the FDA, Centers for Medicare and Medicaid Services (CMS), and National Institutes of Health, as well as many other healthcare leaders. He holds a Bachelor of Science in Business from George Mason University.

Eric A. Bennett

Chairman, Director

Managing Director at Accenture LLP. Member of the NY Bar with 30 years of experience in structuring and negotiating complex deals for digital technology, business operations, and IT transformation in Europe and the US.

Based in Charleston, South Carolina, Eric has closed $8B in large deals across semiconductor, banking insurance, health, travel, telco, and automotive industries.

Clayton Taylor

Director

Clayton Taylor Co-Founder of Thermal Engineering & Equipment LLC . Founded ComRent International LLC that grew to a multinational leading provider of the largest testing solutions in the Data Center, Renewable Energy and Utility vertical markets. ComRent was managed to grow and maintained CAGR to be admitted to INC5000 list for 8 consecutive years. Clay has enjoyed multiple successful business exits with his private equity partners. Clay holds a Bachelor of Science in Management Science and Statistics, with a Minor in Information Systems from the University of Maryland (1988). Clay enjoys spending time with family, in the outdoors including ranching. Clay is a strong supporter of protection of the innocence of children and of parental rights at the state and county levels. Clay likes giving back by public service and serves in county government on a Board and as an audit representative. Clay also serves as the Republican Precinct Committeeman for 503 Sarasota County, Florida.

Ghassan Kassab

Director

Current Chairman of the Board & Research Professor at California Medical Innovations Institute. A Fellow of the American institute for Medical and Biological Engineering, the American Physiological Society Cardiovascular Section, and the American Venous Forum. Editorial Board of American Journal of Physiology-Heart and Circulatory Physiology, Journal of Biomechanics. Dr. Kasab has over 300 issued or pending patents and has published over 700 proceedings, abstracts and full-length publications in his scientific interests which encompass the biomechanics of cardiovascular and gastroenterology systems in health and disease.

Jim Rapp

Director

Jim is a transformative leader with substantial commercial success and reputation as a bold, inclusive leader willing to take calculated risks to drive successful outcomes. Jim has led large teams >$350M and consistently outperformed peers in both share and margin.

Experienced with reorganization initiatives, financial modeling, change management, role/responsibilities, VC planning, and driving results through KPI’s. 24 years of experience at GE Healthcare where he led sales of Cardiovascular Imaging and Invasive Monitoring businesses for Us & Canada serving Interventional cardiology, radiology, vascular surgery, oncology, EP, and neuro markets.

Jim holds a Bachelor of Mechanical Engineering (BME), summa cum laude University of Cincinnati, College of Engineering, Cincinnati Ohio.

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Chief Medical Officer
Interventional Cardiology

Sanjay Bhojraj, M.D., is an interventional cardiologist at Mission Heritage Medical Group in Ladera Ranch, California. He specializes in interventional cardiology and has over 19 years of experience in the field of medicine.

EXPERIENCE
Dr. Sanjay Bhojraj, M.D., is a cardiology specialist in Mission Viejo, CA. Dr. Bhojraj completed a residency at Northwestern Center Feinberg School of Medicine. He currently practices at Mission Heritage Medical Group and is affiliated with Providence Mission Hospital, Mission Viejo. Dr. Bhojraj is board certified in Interventional Cardiology.

EDUCATION

  • Henry Ford Health System, Fellowship Hospital — 2010
  • Northwestern Center Feinberg School of Medicine, Residency Hospital — 2005
  • Northwestern Center Feinberg School of Medicine, Internship Hospital — 2003
  • Indiana University / School of Medicine, Medical School — 2002

Tom Martyak, M.D.

Medical Advisory Board
Cardiovascular Medicine

Tom Martyak, M.D., is Board Certified in Cardiovascular Diseases and Interventional Cardiology.

EXPERIENCE
Dr. Tom Martyak, M.D., served as the cardiac cath lab director at Mary Washington Hospital for 20 plus years. He just retired from that position.

He attended Georgetown University for medical school and then entered the Army. He trained at Walter Reed Medical Center for Cardiology and Interventional Cardiology after a start in Emergency Medicine. Dr. Martyak was Chief of Cardiology at William Beaumont in El Paso, Texas.

He then relocated to Fredericksburg, Virginia, to begin the Interventional cardiology program at Mary Washington Hospital. He has extensive experience with cardiac catheterization, coronary and peripheral vascular intervention, and clinical research. He has lived and practiced in the Fredricksburg area for over 30 years.

Dr. Martyak has a special interest in educating his patients and their family members to their specific cardiac issue, so they can be involved in improving their overall cardiac health. He is currently active in working with the Imago team in preparing for a first submission to FDA for visualization in cardiology.

Patricia Cole - Headshot

Patricia Cole, M.D., Ph.D.

Medical Advisory Board
Radiology - Cardiology - Oncology

Patricia E. Cole, Ph.D., M.D., is Executive Director and Head of the Imaging Strategy Group in the Oncology Strategic Business Unit at Bayer Pharmaceuticals where she is responsible for the imaging biomarker component of oncology drug development plans and for the oversight of imaging biomarkers in oncology clinical trials.

Dr. Cole has had over 20 years of experience in the pharma industry with a focus on biomarkers in clinical trials. She has utilized x-ray, CT, MRI, MR spectroscopy, PET, SPECT, photography, ultrasound and DXA imaging modalities and includes deep learning and radiomics tools in image analysis approaches. Her therapeutic area experience includes CNS, oncology, hematology, cardiovascular, metabolism, diabetes, obesity, arthritis, immunology, inflammation and pulmonology.

Her positions have included:

  • Clinical Director at Novartis, initially in Experimental Clinical Development and then in Biomarker Development; Senior Director and Global Head of Imaging Biomarkers at Eisai Medical Research.
  • Vice President and Head of Imaging Core Lab at ImagePace, LLC.
  • CEO of Cole Imaging and Biomarker Consulting, LLC.
  • Medical Fellow in the Translational Imaging Group, Tailored Therapeutics, Eli Lilly and Company.

Prior to joining Bayer, she served as Executive Director, Translational Research and Early Clinical Imaging at Takeda Pharmaceuticals.

Dr. Cole has also been an active participant in precompetitive space consortia and working groups involving:

  • The advancement of quantitative imaging biomarkers including the Innovative Medicines Initiative in Immune Cell Imaging.
  • Quantitative Imaging Biomarker Alliance (QIBA) where she is a member of the Steering Committee, a member of the Multiparametric Imaging Biomarker Metrology committee and serves as co-chair of the Magnetic Resonance Elastography Biomarker Committee.
  • Alzheimer’s Disease Neuroimaging Initiative (ADNI), for which she served as an Industry Scientific Advisory Board chair, and the Coalition Against Major Diseases (CAMD) where she was involved in qualification of imaging biomarkers for subject enrichment in prodromal AD and in early Parkinson’s Disease trials.

Dr. Cole is a board-certified radiologist with subspecialty qualification in cardiovascular and interventional radiology. She completed her M.D. degree at Albert Einstein College of Medicine and held an American Cancer Society Special Postdoctoral Fellowship during medical school.

Her radiology residency and fellowship were completed at NY Hospital-Cornell Medical Center. Her radiology faculty positions included Memorial Sloan Kettering Cancer Center and Yale-New Haven Medical Center.

Dr. Cole also holds a Ph.D. in biophysical chemistry, and after a postdoctoral fellowship in molecular biology, she held faculty positions in the Department of Chemistry at Columbia University and in molecular Biophysics and Biochemistry at Yale.

Fethi Benraouane, M.D.

Clinical Advisory Board
Cardiologist at Houston Methodist

Specialist in Cardiac Imaging, Cardiology, Interventional Cardiology Peripheral Vascular Disease Cardiology, Preventive Cardiology, Structural Heart Disease Cardiology, Vascular Medicine, Women’s Cardiovascular Disease. Clinical interests in angioplasty, aortic aneurysms, CVA/Stroke, hypertension, and arrhythmias.

Dr. Richard Schatz

Clinical Advisory Board and Consultant
Cardiologist/Scientist

Research Director, Cardiovascular Interventions and the Director, Gene and Stem Cell therapy at the Scripps Heart, Lung, and Vascular Center for over 30 years.

Co-invented the Palmaz-Schatz stent. He won the prestigious Russ Prize for biomedical engineering in 2019, considered the American Nobel Prize.